This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A bicentric open-label, randomized, two-parallel-g...
Clinical trial

A bicentric open-label, randomized, two-parallel-group study investigating the impact of combined Lantus�(insulin glargine) and Lyxumia �(lixisenatide) on insulin secretion and gastric emptying in subjects with Type 2 Diabetes Mellitus not adequately cont

Read time: 1 mins
Last updated:26th Jul 2013
To address in type 2 diabetic patients compared to baseline the effect of repeated doses of Lyxumia� and Lantus� after an eight weeks two-step treatment regimen (four weeks administration of either Lyxumia� or Lantus�, both followed by their combined administration for another four weeks) on intravenous glucose tolerance test (IVGTT) related first phase insulin secretion
Category Value
Study start date 2013-07-26

View full details